Jones Financial Companies
SLS icon

Jones Financial Companies’s SELLAS Life Sciences SLS Stock Holding History

Jones Financial Companies’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.6M Buy
2,304,561
+629,484
+38% +$4.35M 0.01% 566
2026
Q1 		$7.31M Buy
1,675,077
+1,245,834
+290% +$5.57M ﹤0.01% 934
2025
Q4 		$1.62M Buy
429,243
+428,869
+114,671% +$834K ﹤0.01% 1047
2025
Q3 		$610 Hold
374
– – ﹤0.01% 3998
2025
Q2 		$729 Hold
374
– – ﹤0.01% 3728
2025
Q1 		$415 Hold
374
– – ﹤0.01% 3533
2024
Q4 		$389 Hold
374
– – ﹤0.01% 3258
2024
Q3 		$471 Hold
374
– – ﹤0.01% 2893
2024
Q2 		$445 Buy
+374
New +$509 ﹤0.01% 2352

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jones Financial Companies's SLS Position: Q2 2026 in Review

Jones Financial Companies increased its SELLAS Life Sciences (SLS) stake by 38% in Q2 2026, buying an estimated $4.35M and bringing the position to 2,304,561 shares worth $28.6M. The position accounts for 0.01% of the portfolio, ranked #566.

Jones Financial Companies first reported a position in SLS in Q2 2024 and has held it in 9 quarters since. 193 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Jones Financial Companies held 2,304,561 shares of SELLAS Life Sciences worth $28.6M as of Q2 2026.
  • Jones Financial Companies bought 629,484 SELLAS Life Sciences shares in Q2 2026, an estimated $4.35M.
  • SELLAS Life Sciences made up 0.01% of Jones Financial Companies's portfolio in Q2 2026, its #566 holding.
  • Jones Financial Companies first reported a position in SELLAS Life Sciences in Q2 2024 and has held it in 9 quarters since.
  • 193 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.